SGRY Valuation

Surgery Partners Inc

Add to Watchlist

Advanced Chart

20.870

-0.570(-2.660%)

Overview
Forecast
Valuation

SGRY Relative Valuation

SGRY's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SGRY is overvalued; if below, it's undervalued.

Historical Valuation

Surgery Partners Inc (SGRY) is now in the Fair zone, suggesting that its current forward PS ratio of 0.80 is considered Fairly compared with the five-year average of 1.19. The fair price of Surgery Partners Inc (SGRY) is between 18.82 to 37.93 according to relative valuation methord.

Relative Value

Fair Zone

18.82-37.93

Current Price：20.87

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.51

P/B

Median3y

2.08

Median5y

4.18

7.72

FCF Yield

Median3y

3.78

Median5y

6.01

Competitors Valuation Multiple

The average P/S ratio for SGRY's competitors is 0.59, providing a benchmark for relative valuation. Surgery Partners Inc Corp (SGRY) exhibits a P/S ratio of 0.80, which is 35.99% above the industry average. Given its robust revenue growth of 14.29%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap